Search

Displaying results 41 - 50 of 78 in total
  1. Indication

    Nonsmall Cell Lung Cancer, Stage II

    go.drugbank.com/conditions/DBCOND0129475
    Drugs: Atezolizumab · Pembrolizumab
  2. Indication

    Advanced Microsatellite Instability High Endometrial Carcinoma

    go.drugbank.com/conditions/DBCOND0147954
    Drugs: Dostarlimab · Pembrolizumab
  3. Indication

    Metastatic Microsatellite Instability High Colorectal Cancer

    go.drugbank.com/conditions/DBCOND0144308
    Drugs: Nivolumab · Pembrolizumab
  4. Indication

    Metastatic Adenocarcinoma of the Gastroesophageal Junction

    go.drugbank.com/conditions/DBCOND0069248
    Drugs: Pembrolizumab · Trastuzumab
  5. Indication

    Persistent Cervical Cancer

    go.drugbank.com/conditions/DBCOND0125497
    Drugs: Bevacizumab · Pembrolizumab
  6. Indication

    Stage III Melanoma

    go.drugbank.com/conditions/DBCOND0028661
    Drugs: Pembrolizumab · Trametinib
  7. Indication

    Metastatic HER2 negative Gastric Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0162412
    Drugs: Pembrolizumab · Tislelizumab
  8. Indication

    Metastatic HER2 negative Gastroesophageal Junction Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0171123
    Drugs: Pembrolizumab · Tislelizumab
  9. Indication

    Metastatic Mismatch Repair Deficient Colorectal Cancer

    go.drugbank.com/conditions/DBCOND0144310
    Drugs: Nivolumab · Pembrolizumab
  10. Indication

    Unresectable Microsatellite Instability High Colorectal Cancer

    go.drugbank.com/conditions/DBCOND0144306
    Drugs: Nivolumab · Pembrolizumab